# Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis

> **NCT01707472** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 18 (actual)

## Conditions studied

- Liver Fibrosis
- Hepatitis C
- HIV
- HIV/HCV Co-infection

## Interventions

- **BIOLOGICAL:** Simtuzumab

## Key facts

- **NCT ID:** NCT01707472
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-04
- **Primary completion:** 2014-10-17
- **Final completion:** 2014-10-17
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01707472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01707472, "Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01707472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*